CHICAGO, Oct. 5, 2015 /PRNewswire/ -- Invuity, Inc.
(NASDAQ:IVTY), an advanced medical technology company, today
announced the introduction of its Eikon™ LT illuminated retractor
system, expanding the company's portfolio of devices that improve
intra-cavity illumination and visualization. Eikon LT integrates
Invuity's Intelligent Photonics™ technology to enable minimally
invasive and minimal access open surgeries, including breast
oncology and reconstruction, thyroid oncology and general surgery.
As showcased at the American College of Surgeons (ACS) Clinical
Congress in Chicago, the Eikon LT
system expands the existing Eikon platform while integrating design
enhancements that further enable surgical precision, efficiency and
safety.
The next-generation Eikon LT platform addresses key safety
priorities for hospitals and health systems. As the numbers of
minimally invasive surgeries rise, electrosurgical devices have
shown to be potential sources of thermal burns and operating room
fires. In response to hospital initiatives focused on ensuring
safety during minimally invasive surgeries, Invuity engineered a
proprietary high performance material. This reinforced polymer
material is 100 percent non-conductive, eliminating the risks
related to overheating, and the potential for burns due to arcing
from electrosurgical devices. Eikon LT's non-conductive material,
coupled with its proprietary thermally cool illumination, virtually
eliminates the known thermal hazards associated with traditional
electrosurgical devices and fiber optics.
Forty percent lighter than traditional retractors, Eikon LT also
helps reduce fatigue and improves efficiency for surgeons operating
through deep, dark cavities while using smaller incisions.
Additional enhancements to the blade and tip further enable
surgeons to optimize clinical and cosmetic outcomes in minimally
invasive procedures – including Hidden Scar™ Breast Cancer Surgery.
The device's smooth edges reduce tissue trauma and allow for easy
maneuverability, while flexibility in the blade puts less tension,
stress and trauma on the breast flap to maintain flap viability and
integrity.
"The Eikon LT's lightweight design and flexible blade enable me
to operate more efficiently, and improve breast flap viability
without the worry of burn injury," said Sunny Mitchell, MD, Associate Chairperson of
Surgery and Director of Women's Health Services at Coney Island
Hospital. "This type of innovation enables enhancements in surgical
technique that improve patient safety and the overall patient
experience."
Eikon LT accommodates multiple hand positions for various hand
sizes, and offers an improved ergonomic design that reduces surgeon
fatigue. Grooves in the handle and thumb slots provide for a
comfortable grip that also prevents hand slippage, further
improving the surgeon's precision. To accommodate physician
preferences and varying patient anatomies, the Eikon LT is
available in multiple sizes, with eight retractors in the system
ranging from 40mm to 175mm.
"We're continually looking for innovative ways to address
real-world needs for healthcare providers and to drive clinical
improvements in minimal access surgery," said Paul Davison, Vice President of Research and
Development at Invuity. "One way to do that is to provide thermally
cool illumination and eliminate the potential for patient burns. We
developed a proprietary reinforced polymer material for Eikon LT
that is 100 percent non-conductive, improving safety in the
operating room and further reducing the risk of burns caused by
electrosurgical device arcing."
The Eikon LT illuminated retractor system is commercially
available beginning today. For more information, please visit booth
#1235 at ACS 2015 or www.invuity.com/products/retractors.
About Invuity®
Invuity, Inc. is a medical
technology company focused on developing and marketing advanced
photonics devices to improve the ability of surgeons to illuminate
and visualize the surgical cavity during minimally invasive and
minimal access open surgery. The company's patented Intelligent
Photonics™ technology enables enhanced surgical precision,
efficiency and safety by providing superior visualization. Clinical
applications include breast and thyroid oncology, plastic
reconstructive, spine, orthopedic, cardiothoracic and general
surgery among others. Invuity is headquartered
in San Francisco, CA. For more information, visit
www.invuity.com.
Forward-Looking Statements
This announcement contains
forward-looking statements that involve risks and uncertainties,
including statements regarding market opportunities and potential
results from future new initiatives. Actual results could differ
materially from those projected in the forward-looking statements
as a result of certain risk factors, including, but not limited to:
fluctuations in demand or failure to gain market acceptance for the
Company's devices; the Company's ability to demonstrate to and gain
approval from hospitals to use the Company's devices; the highly
competitive business environment for surgical medical devices; the
Company's ability to sell its devices at prices that support its
current business strategies; difficulty forecasting future
financial performance; protection of the Company's intellectual
property; and compliance with necessary regulatory clearances or
approvals. The Company undertakes no obligation to update the
forward-looking information in this release. More information about
potential factors that could affect the Company's business and
financial results is included in its filings with the Securities
and Exchange Commission, including, without limitation, under the
captions: "Management's Discussion and Analysis of Financial
Condition and Results of Operations," and "Risk Factors," which are
on file with the Securities and Exchange Commission.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/invuity-announces-launch-of-eikon-lt-illuminated-retractor-system-at-american-college-of-surgeons-2015-clinical-congress-300153610.html
SOURCE Invuity, Inc.